These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29731713)

  • 1. Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors.
    Horenstein AL; Chillemi A; Zini R; Quarona V; Bianchi N; Manfredini R; Gambari R; Malavasi F; Ferrari D
    Front Pharmacol; 2018; 9():196. PubMed ID: 29731713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD56brightCD16- NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+ T Cell Proliferation.
    Morandi F; Horenstein AL; Chillemi A; Quarona V; Chiesa S; Imperatori A; Zanellato S; Mortara L; Gattorno M; Pistoia V; Malavasi F
    J Immunol; 2015 Aug; 195(3):965-72. PubMed ID: 26091716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectonucleotidase Expression on Human Amnion Epithelial Cells: Adenosinergic Pathways and Dichotomic Effects on Immune Effector Cell Populations.
    Morandi F; Horenstein AL; Quarona V; Faini AC; Castella B; Srinivasan RC; Strom SC; Malavasi F; Gramignoli R
    J Immunol; 2019 Feb; 202(3):724-735. PubMed ID: 30587530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation.
    Morandi F; Morandi B; Horenstein AL; Chillemi A; Quarona V; Zaccarello G; Carrega P; Ferlazzo G; Mingari MC; Moretta L; Pistoia V; Malavasi F
    Oncotarget; 2015 Sep; 6(28):25602-18. PubMed ID: 26329660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A CD38/CD203a/CD73 ectoenzymatic pathway independent of CD39 drives a novel adenosinergic loop in human T lymphocytes.
    Horenstein AL; Chillemi A; Zaccarello G; Bruzzone S; Quarona V; Zito A; Serra S; Malavasi F
    Oncoimmunology; 2013 Sep; 2(9):e26246. PubMed ID: 24319640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canonical and non-canonical adenosinergic pathways.
    Ferretti E; Horenstein AL; Canzonetta C; Costa F; Morandi F
    Immunol Lett; 2019 Jan; 205():25-30. PubMed ID: 29550257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Extracellular Adenosine Generation in the Development of Autoimmune Diseases.
    Morandi F; Horenstein AL; Rizzo R; Malavasi F
    Mediators Inflamm; 2018; 2018():7019398. PubMed ID: 29769837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvesicles expressing adenosinergic ectoenzymes and their potential role in modulating bone marrow infiltration by neuroblastoma cells.
    Morandi F; Marimpietri D; Horenstein AL; Corrias MV; Malavasi F
    Oncoimmunology; 2019; 8(5):e1574198. PubMed ID: 31069133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD
    Morandi F; Marimpietri D; Horenstein AL; Bolzoni M; Toscani D; Costa F; Castella B; Faini AC; Massaia M; Pistoia V; Giuliani N; Malavasi F
    Oncoimmunology; 2018; 7(8):e1458809. PubMed ID: 30221054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD38 in Adenosinergic Pathways and Metabolic Re-programming in Human Multiple Myeloma Cells: In-tandem Insights From Basic Science to Therapy.
    Horenstein AL; Bracci C; Morandi F; Malavasi F
    Front Immunol; 2019; 10():760. PubMed ID: 31068926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles and Modalities of Ectonucleotidases in Remodeling the Multiple Myeloma Niche.
    Chillemi A; Quarona V; Antonioli L; Ferrari D; Horenstein AL; Malavasi F
    Front Immunol; 2017; 8():305. PubMed ID: 28373875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypical analysis of ectoenzymes CD39/CD73 and adenosine receptor 2A in CD4
    Han L; Sugiyama H; Zhang Q; Yan K; Fang X; McCormick TS; Cooper KD; Huang Q
    Australas J Dermatol; 2018 Feb; 59(1):e31-e38. PubMed ID: 28295154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unconventional, adenosine-producing suppressor T cells induced by dendritic cells exposed to BPZE1 pertussis vaccine.
    Fedele G; Sanseverino I; D'Agostino K; Schiavoni I; Locht C; Horenstein AL; Malavasi F; Ausiello CM
    J Leukoc Biol; 2015 Oct; 98(4):631-9. PubMed ID: 26089537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unraveling the contribution of ectoenzymes to myeloma life and survival in the bone marrow niche.
    Quarona V; Ferri V; Chillemi A; Bolzoni M; Mancini C; Zaccarello G; Roato I; Morandi F; Marimpietri D; Faccani G; Martella E; Pistoia V; Giuliani N; Horenstein AL; Malavasi F
    Ann N Y Acad Sci; 2015 Jan; 1335():10-22. PubMed ID: 25048519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine Generated in the Bone Marrow Niche Through a CD38-Mediated Pathway Correlates with Progression of Human Myeloma.
    Horenstein AL; Quarona V; Toscani D; Costa F; Chillemi A; Pistoia V; Giuliani N; Malavasi F
    Mol Med; 2016 Dec; 22():694-704. PubMed ID: 27761584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents.
    Costa F; Dalla Palma B; Giuliani N
    Cells; 2019 Dec; 8(12):. PubMed ID: 31847204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATP and Its Metabolite Adenosine as Regulators of Dendritic Cell Activity.
    Silva-Vilches C; Ring S; Mahnke K
    Front Immunol; 2018; 9():2581. PubMed ID: 30473700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft-versus-host disease.
    Geraghty NJ; Watson D; Sluyter R
    Immunol Cell Biol; 2019 Jul; 97(6):597-610. PubMed ID: 30957314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inversed Ratio of CD39/CD73 Expression on γδ T Cells in HIV Versus Healthy Controls Correlates With Immune Activation and Disease Progression.
    Kolbe K; Wittner M; Hartjen P; Hüfner AD; Degen O; Ackermann C; Cords L; Stellbrink HJ; Haag F; Schulze Zur Wiesch J
    Front Immunol; 2022; 13():867167. PubMed ID: 35529864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation in CD39/CD73 Axis May Trigger the Upsurge of the Immune Suppressive Agent Adenosine in OSA Patients.
    Díaz-García E; García-Sánchez A; Alfaro E; López-Fernández C; Mañas E; Casitas R; Vega S; Cano-Pumarega I; García-Río F; Cubillos-Zapata C
    Arch Bronconeumol; 2024 Apr; 60(4):207-214. PubMed ID: 38485582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.